BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343 [PMID: 37545640 DOI: 10.3748/wjg.v29.i27.4334]
URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm
Number Citing Articles
1
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao. Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysisFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1441785
2
AzathioprineReactions Weekly 2023; 1976(1): 66 doi: 10.1007/s40278-023-46795-7
3
Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment optionWorld Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386
4
Gulshan Rathi, Prashant B. Shamkuwar, Karishma Rathi, Ruchita Ranazunjare, Soham Kulkarni. Contemporary and prospective use of azathioprine (AZA) in viral, rheumatic, and dermatological disorders: a review of pharmacogenomic and nanotechnology applicationsNaunyn-Schmiedeberg's Archives of Pharmacology 2024;  doi: 10.1007/s00210-024-03569-8